FCPA & Anti-Corruption for the Life Sciences Industry Conference

On May 11, Washington, D.C. litigation head Jennifer Bragg participated in the panel “Maintaining Effective and Compliant HCP Relations in Practice: How Life Sciences Companies are Dovetailing Operationally Efficient Processes With Required Checks and Balances” during ACI’s FCPA & Anti-Corruption for the Life Sciences Industry Conference. Topics included operationalizing compliant health care personnel (HCP) engagement strategies, and key violations and investigations involving interactions with HCP, among others.

BACK TO TOP